We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

16 hedge funds and large institutions have $7.83M invested in Biolase, Inc. in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more funds holding

Funds holding: 13 → 16 (+3)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

36% less capital invested

Capital invested by funds: $12.2M → $7.83M (-$4.35M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
Archon Capital Management
Washington
+$125K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$29.6K
3
RJFSA
Raymond James Financial Services Advisors
Florida
+$13.2K
4
Victory Capital Management
Victory Capital Management
Texas
+$3.29K

Top Sellers

Rank Fund Capital Flow
1
TMC
Trellus Management Company
Florida
-$132K
2
BlackRock
BlackRock
New York
-$3.29K
Name Holding Trade Value Shares
Change 		Change in
Stake
OIM
1
Oracle Investment Management
Connecticut
$4.86M – – –
ACM
2
Archon Capital Management
Washington
$1.56M +$125K +38 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$930K +$29.6K +9 +2%
BlackRock
4
BlackRock
New York
$279K -$3.29K -1 -0.8%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$46K – – –
Northern Trust
6
Northern Trust
Illinois
$34K – – –
California Public Employees Retirement System
7
California Public Employees Retirement System
California
$32K – – –
TA
8
Teton Advisors
New York
$21K – – –
TMC
9
Trellus Management Company
Florida
$15K -$132K -40 -85%
RJFSA
10
Raymond James Financial Services Advisors
Florida
$11K +$13.2K +4 New
Bank of New York Mellon
11
Bank of New York Mellon
New York
$10K – – –
Morgan Stanley
12
Morgan Stanley
New York
$8K – – –
UBS Group
13
UBS Group
Switzerland
$8K – – –
TFO
14
Tarbox Family Office
California
$7K – – –
Victory Capital Management
15
Victory Capital Management
Texas
$3K +$3.29K +1 New
IA
16
IFP Advisors
Florida
$2K +$3.29K +1 New
HFM
17
Hartford Financial Management
Connecticut
$1K – – –
LTFS
18
Ladenburg Thalmann Financial Services
Florida
$1K – – –
APA
19
American Portfolios Advisors
New York
$384 – – –

BIOL Hedge Fund Activity: Q3 2019 in Review

16 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2019, worth a combined $7.83M — down 36% from $12.2M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BIOL positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Archon Capital Management, adding an estimated $125K. The largest seller was Trellus Management Company, cutting an estimated $132K.

  • 16 institutional investors held Biolase, Inc. (BIOL) as of Q3 2019, up from 13 in Q2 2019.
  • Funds reported $7.83M of Biolase, Inc. stock for Q3 2019, down 36% quarter-over-quarter.
  • 3 funds opened new Biolase, Inc. positions in Q3 2019 and 0 closed out, a net change of +3 holders.
  • The largest Biolase, Inc. buyer in Q3 2019 was Archon Capital Management, an estimated $125K added.
  • The largest Biolase, Inc. seller in Q3 2019 was Trellus Management Company, an estimated $132K sold.

Based on aggregated 13F filings for Q3 2019.